Data Material
ALK Medical Affairs North America provides the resources found on this website for U.S. healthcare professionals only.
Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen–Induced Rhinoconjunctivitis
Journal Publication
Click to view
By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.